KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pfizer (PFE) Net Income towards Common Stockholders (2016 - 2026)

Pfizer has reported Net Income towards Common Stockholders over the past 18 years, most recently at -$13.0 million for Q1 2026.

  • Quarterly Net Income towards Common Stockholders changed N/A to -$13.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $12.0 million through Mar 2026, up 33.33% year-over-year, with the annual reading at $25.0 million for FY2025, 127.27% up from the prior year.
  • Net Income towards Common Stockholders was -$13.0 million for Q1 2026 at Pfizer, down from $25.0 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $34.0 million in Q3 2022 and troughed at -$26.0 million in Q4 2023.
  • The 5-year median for Net Income towards Common Stockholders is -$3.5 million (2023), against an average of $416666.7.
  • Year-over-year, Net Income towards Common Stockholders plummeted 1000.0% in 2022 and then soared 950.0% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$21.0 million in 2022, then fell by 23.81% to -$26.0 million in 2023, then soared by 69.23% to -$8.0 million in 2024, then skyrocketed by 412.5% to $25.0 million in 2025, then crashed by 152.0% to -$13.0 million in 2026.
  • Per Business Quant, the three most recent readings for PFE's Net Income towards Common Stockholders are -$13.0 million (Q1 2026), $25.0 million (Q2 2025), and -$8.0 million (Q3 2024).